‘Udupi Helpline’ to transport excess food from wedding halls to the needy

Mangaluru, Jul 2: A middle aged man who was battling health issues due to kidney-related ailments, breathed his last at a private hospital.

He was tested positive for coronavirus.

The deceased was a 49-year-old resident of Kalladka in Bantwal.

According to sources, the man, was getting treated for tuberculosis and liver-related ailments, he was at home since 20 days.

On June 27 he was admitted to the private hospital in the city due to kidney related ailment.

With this, the total number of death of covid patients in the district reached to 18.

Bengaluru, Jul 10: Karnataka Chief Minister BS Yediyurappa has quarantined himself at his personal residence after three persons posted at his official residence 'Krishna' tested positive for COVID-19. The Chief Minister, who held a cabinet meeting and also visited Karnataka's largest COVID-19 care centre on Thursday, has cancelled all his engagements scheduled for Friday.

In a statement issued on Friday afternoon, Yediyurappa said that he was healthy and will continue to work from his residence. The Chief Minister will remain in home quarantine till next week as protocol mandates. Three persons -- an electrician, a standby driver and a pilot vehicle staffer -- have tested positive for COVID-19.

"Since a few staff at my official residence Krishna have tested positive for COVID19, I will be working from my personal residence for the next few days. I will hold meetings, consultations and issue orders and suggestions via video conferencing. There is no need to worry. I am healthy. I appeal to everyone to take all precautionary measures and follow protocols issued by the government. Wear masks and ensure social distancing and help us contain COVID19," a statement from the Chief Minister said.

Bengaluru, Mar 27: Oncologist Dr. Vishal Rao, HCG Hospital Bengaluru on Friday said that human body cells release interferon chemical to kill viruses but it cannot be released by cells in the case of COVID-19 cases, leading to weak immune system. However, a therapy of specific concoction could be useful in treating COVID-19 patients.

"We got hold of some preprint suggesting that interferon is effective in COVID19," said Rao.

Speaking to news agency, he continued saying "When we withdraw blood for regular check-ups, we get buffy coat which can be used to take out cells and form interferon. These two chemicals and some other cytokines, in a specific concoction, could be potentially very useful in treating COVID-19 patients."

Rao said that they have built a concoction of cytokines which can be injected to reactivate immune system in COVID-19 patients.

"We are in a very initial stage and hope to be ready with its first set by this weekend. We have applied to the governement for an expedited review. We have also presented this before the state government" said Rao.

"We have a team of infection specialist, ICU team and other...all of us have worked together to build something that we believe. We want to serve the society at this hour of need," he added.

Dr Rao clarified that this is not a vaccine and this particular interferon therapy does not help to prevent the infection of COVID-19. However, this is focused and targeted towards COVID-19 positive patients or those who have just incubated the virus.

"We believe that in early stages as well as the patients who have just incubated, this particular therapy of interferon gama and other concoction of cytokines could be an effective method. In the late stages we are looking at specific dosage of the cells which are our own body cells which can actually be affective and could also be of use for the ventilator patients," he added.

Meanwhile, Dr Gururaj, Immunologist and Scientist told ANI that they are trying to cover two aspects, one is the early stage patients where they are trying to improve their immune systems.

"As Dr Vishal said, we are trying to see whether we can use the cytokines from our own immune cells which is a natural process but it is hampered in infected patients," said Dr Gururaj.

"In the last phase we are using cells which are used from the bone marrow of the patient or donors. We can use those cells to reduce the inflation and so called cytokines release syndrome which is basically the inflammatory response of the body," he added.